Search results
New COVID-19 vaccine for fall should target JN.1 lineage, not variant,FDA panel
USA TODAY via Yahoo News· 47 minutes agoOn Wednesday, the panel didn’t say whether older people would need boosters. The recommendations...
FDA to vote Wednesday on COVID-19 shots to target emerging variants in US for 2024-25
Detroit News· 17 hours agoA U.S. Food and Drug Administration advisory committee will meet Wednesday to recommend a COVID-19...
FDA Panel to Consider Updating COVID-19 Jabs for New Virus Strains
Zacks via Yahoo Finance· 1 day agoAn FDA panel meeting is scheduled on Jun 5 to consider if COVID-19 vaccines should be updated to...
FDA vaccine advisors expected to vote on new COVID-19 booster formula
ABC Action News Tampa Bay· 1 day agoThe FDA’s vaccine advisory committee is expected to meet Tuesday. It was postponed due to the...
FDA confirms robotic prostatectomy survival rates match traditional surgery By Investing.com
Investing.com· 2 hours agoThe U.S. Food and Drug Administration (FDA) has approved a labeling revision for Intuitive's da...
COVID shots should target variants with JN.1 lineage in 2024-25 campaign, US FDA advisers say By...
Investing.com· 7 hours agoAll 16 voting members of the panel recommended that FDA ask companies target the JN.1 variant or a...
What should you do if you’re still testing positive for COVID-19 after day 10?
The Today Show via AOL· 18 hours agoDepending on your symptoms and exposure, you may want to take a third rapid test another 48 hours...
Will there be new COVID-19 booster for fall 2024?
WCVB Boston· 5 days agoWill there be new COVID-19 booster for fall 2024?
FDA approves Moderna’s RSV vaccine mRESVIA
Pharmaceutical Technology via Yahoo Finance· 2 days agoNo serious safety issues were reported, with the most common adverse reactions being injection site pain and fatigue. Moderna CEO Stéphane Bancel stated:...
COVID shots should target JN.1 or newer variants in 2024-25 campaign, US FDA advisers say
Reuters via Yahoo News· 53 minutes ago(Reuters) - Advisers to the U.S. Food and Drug Administration on Wednesday unanimously voted in...